CMS announced an increase in Medicare payment for at-home administration of COVID-19 vaccines. Medicare will now pay $75 per at-home dose, nearly double its previous $40 adminitration rate.
CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.
Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.
Ronald Hirsch, MD, FACP, CHCQM, CHRI, examines recent changes to commercial payer prior authorization requirements and how it affects revenue integrity.
NAHRI Advisory Board member John Settlemyer, MBA, MHA, CPC, CHRI, will walk attendees through the coding and billing processes for new technology in both inpatient and outpatient settings.
NAHRI Advisory Board member Denise Williams, COC, CHRI, discusses AUC reporting requirements, how to access the criteria, processes to support reporting, and how to ensure that all information is available and reported on the claim.
The following is an excerpt from the May 20 episode of The Revenue Integrity Show: A NAHRI Podcast in which we covered the 2022 IPPS proposed rule with guest Jugna Shah, MPH, CHRI, President, Nimitt Consulting Inc., in Spicer, Minnesota.